ORIC Pharmaceuticals, Inc. (ORIC)

ORIC Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	49.33	59.41	23.38	66.84	226.01	78.45
Short-Term Investments	154.39	196.55	184.8	139.43	10.97	215.15
Cash & Short-Term Investments	203.72	255.96	208.19	206.27	236.98	293.6
Cash Growth	-35.69%	22.95%	0.93%	-12.96%	-19.29%	229.30%
Prepaid Expenses	7.71	6.29	4.41	4.18	3.54	3.1
Total Current Assets	211.43	262.25	212.6	210.46	240.52	296.7
Property, Plant & Equipment	3.02	11.3	12.01	14.24	14.21	1.98
Long-Term Investments	20.04	-	26.85	21.95	43.39	-
Other Long-Term Assets	8.37	0.59	0.55	0.53	0.52	0.32
Total Assets	242.86	274.14	252.01	247.18	298.64	299
Accounts Payable	5.16	1.55	0.94	1.32	1.89	0.76
Accrued Expenses	9.24	20.12	16.76	11.41	11.34	7.7
Current Portion of Leases	3.21	3.18	2.75	2.66	1.93	-
Other Current Liabilities	-	-	-	-	-	0.55
Total Current Liabilities	17.62	24.85	20.46	15.39	15.15	9
Long-Term Leases	5.5	6.17	7.46	9.44	10.52	-
Other Long-Term Liabilities	-	-	-	-	-	0.22
Total Liabilities	23.12	31.02	27.92	24.83	25.67	9.22
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-In Capital	812.32	805.51	658.75	557.87	518.18	456.2
Retained Earnings	-592.8	-562.77	-434.93	-334.23	-245.11	-166.39
Comprehensive Income & Other	0.21	0.38	0.26	-1.29	-0.1	-0.03
Total Common Equity	219.74	243.12	224.09	222.35	272.98	289.78
Shareholders' Equity	219.74	243.12	224.09	222.35	272.98	289.78
Total Liabilities & Equity	242.86	274.14	252.01	247.18	298.64	299
Total Debt	8.72	9.36	10.21	12.1	12.44	-
Net Cash (Debt)	195.01	246.6	197.97	194.17	224.54	293.6
Net Cash Growth	-36.49%	24.56%	1.96%	-13.52%	-23.52%	229.30%
Net Cash Per Share	2.76	3.54	3.85	4.90	5.92	13.38
Filing Date Shares Outstanding	71.09	71.03	67.38	45.09	39.43	36.7
Total Common Shares Outstanding	71.08	71.02	54.87	45.09	39.43	36.67
Working Capital	193.82	237.4	192.14	195.07	225.37	287.7
Book Value Per Share	3.09	3.42	4.08	4.93	6.92	7.90
Tangible Book Value	219.74	243.12	224.09	222.35	272.98	289.78
Tangible Book Value Per Share	3.09	3.42	4.08	4.93	6.92	7.90
Machinery	8.74	8.36	7.39	7.07	5.69	4.76
Leasehold Improvements	2.06	2.04	1.97	1.98	1.71	1.71

Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q